IlluminOss Medical Gains FDA De Novo Clearance for Bone Stabilization

IlluminOss Medical received FDA de novo clearance for the IlluminOss Bone Stabilization System to treat impending and actual pathological fractures of the humerus, radius and ulna resulting from metastatic bone disease. U.S. launch is slated for 2Q18.

The system's first procedure and CE Mark approval occurred in 2009, and it has been...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us